Apogee Therapeutics (NASDAQ:APGE) Earns Buy Rating from Analysts at BTIG Research
BTIG Research assumed coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a report released on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $43.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. William Blair reiterated an outperform rating and issued […]
More Stories
Altus Power, Inc. (NYSE:AMPS) Sees Large Drop in Short Interest
Altus Power, Inc. (NYSE:AMPS – Get Free Report) was the target of a large decrease in short interest in October....
Short Interest in Nicolet Bankshares, Inc. (NYSE:NIC) Drops By 22.6%
Nicolet Bankshares, Inc. (NYSE:NIC – Get Free Report) saw a large decline in short interest in the month of October....
Ahead of G20 Summit in Brazil, Guterres urges bloc to take the lead in tackling global problems
The G20 group of developed economies must be at the forefront of global efforts to bring about peace, climate action, updated...
Beamr Imaging Ltd. (NASDAQ:BMR) Short Interest Up 12.2% in October
Beamr Imaging Ltd. (NASDAQ:BMR – Get Free Report) saw a large increase in short interest during the month of October....
Bragg Gaming Group Inc. (NASDAQ:BRAG) Sees Significant Growth in Short Interest
Bragg Gaming Group Inc. (NASDAQ:BRAG – Get Free Report) was the target of a significant growth in short interest in...
Bank7 Corp. (NASDAQ:BSVN) Short Interest Up 7.1% in October
Bank7 Corp. (NASDAQ:BSVN – Get Free Report) was the target of a significant increase in short interest during the month...